| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 25.79 mm | 25.79 mm | 25.79 mm | 25.79 mm | 25.79 mm | 25.79 mm |
| Cash burn (monthly) | 2.70 mm | 2.50 mm | 4.15 mm | 8.48 mm | 5.41 mm | 6.06 mm |
| Cash used (since last report) | 7.53 mm | 6.96 mm | 11.55 mm | 23.63 mm | 15.07 mm | 16.89 mm |
| Cash remaining | 18.27 mm | 18.84 mm | 14.24 mm | 2.17 mm | 10.73 mm | 8.90 mm |
| Runway (months of cash) | 6.8 | 7.5 | 3.4 | 0.3 | 2.0 | 1.5 |
| 13F holders | Current |
|---|---|
| Total holders | 66 |
| Opened positions | 19 |
| Closed positions | 10 |
| Increased positions | 13 |
| Reduced positions | 15 |
| 13F shares | Current |
|---|---|
| Total value | 8.24 bn |
| Total shares | 44.74 mm |
| Total puts | 400.00 |
| Total calls | 21.10 k |
| Total put/call ratio | 0.0 |
| Largest owners | Shares | Value |
|---|---|---|
| Perceptive Advisors | 12.76 mm | $3.28 bn |
| NBVM GP | 5.89 mm | $15.13 mm |
| Citadel Advisors | 4.77 mm | $1.23 bn |
| Samsara BioCapital | 3.28 mm | $895.00 k |
| BLK BlackRock | 2.99 mm | $769.36 mm |
| Samsara BioCapital | 2.78 mm | $714.53 mm |
| Vanguard | 1.78 mm | $457.27 mm |
| Venrock Healthcare Capital Partners II | 1.20 mm | $328.00 k |
| Polaris Venture Partners V | 1.10 mm | $0.00 |
| Ikarian Capital | 1.06 mm | $271.61 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Dec 24 | Waksal Harlan | RSU Common Stock | Grant | Dispose A | No | No | 0 | 128,333 | 0.00 | 0 |
| 9 Dec 24 | Maria Palasis | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 6.07 | 183,333 | 1.11 mm | 183,333 |
| 16 Oct 24 | Maria Palasis | Common Stock | Grant | Acquire A | No | No | 0 | 300,000 | 0.00 | 300,000 |
| 16 Oct 24 | Jason Cavalier | Common Stock | Grant | Acquire A | No | No | 0 | 100,000 | 0.00 | 100,000 |
| 13 Jun 24 | Altman Michael Seth | Stock Option Common Stock | Grant | Acquire A | No | No | 0.31 | 30,000 | 9.30 k | 30,000 |
